Pharmaceutical Executive-05-01-2011

Issue PDF
Pharmaceutical Executive

May 01, 2011

Sizing Up For Success

Pharmaceutical Executive
Sponsored Content

May 01, 2011

Rising income per capita and a budding consumer health consciousness are fueling a CAGR of 9.5%, giving investors plenty of room to expand market penetration

Pharmaceutical Executive
Features

May 01, 2011

Cloud computing is slowly but surely becoming the IT platform of choice for the industry. Pharm Exec looks at how it now affects nearly every aspect of the pharma business.

Columns
Pharmaceutical Executive

May 01, 2011

According to Eli Lilly, managing alliances requires more than good people skills

Columns
Pharmaceutical Executive

May 01, 2011

The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance

Pharmaceutical Executive

To what extent are generics companies obligated by law to request labeling changes with FDA?

Columns
Pharmaceutical Executive

May 01, 2011

Innovator and generics companies are colliding as they invade each other's turf

Pharmaceutical Executive

Online sentiment analysis monitoring can help biopharma resource managers make crucial decisions

Pharmaceutical Executive
Columns

May 01, 2011

Why is building a successful marketing program so difficult? It should be simple, if your product is worth marketing.

Pharmaceutical Executive
Features

May 01, 2011

Who's taken this year's top spot? Find out in Pharm Exec's annual run-down of the world's Top 50 pharma companies.

Pharmaceutical Executive
Columns

May 01, 2011

The sleek, portable iPad, coupled with customized apps, gives sales reps a leg up

Pharmaceutical Executive
Sponsored Content

May 01, 2011

Considering Big Pharma's trade objectives, the success of regional regulatory harmonization is not insignificant

Pharmaceutical Executive
Columns

May 01, 2011

Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies

Columns
Pharmaceutical Executive

May 01, 2011

The EU is largely powerless when it comes to policies over pricing and reimbursement

Pharmaceutical Executive
Columns

May 01, 2011

A factory tour to examine Merck's automated robots-and the human minds that inspire them

Pharmaceutical Executive
From the Editor

May 01, 2011

What do the Pharm Exec 50 numbers tell us? The dominant theme seems to be one of gradual restructuring toward a post-patent-cliff era.

Pharmaceutical Executive
Features

May 01, 2011

The pharmaceutical industry needs to use new and better data to accurately measure how much it is willing to invest in avoiding plan control